IceCure Medical (ICCM) Projected to Post Earnings on Thursday

IceCure Medical (NASDAQ:ICCM) is expected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $1.07 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

IceCure Medical Trading Down 8.5 %

NASDAQ:ICCM opened at $1.18 on Wednesday. The business’s 50-day moving average is $1.32 and its two-hundred day moving average is $0.98. The firm has a market capitalization of $65.49 million, a PE ratio of -4.07 and a beta of 0.37. IceCure Medical has a 12 month low of $0.48 and a 12 month high of $1.66. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.67 and a quick ratio of 2.27.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and set a $2.50 price target on shares of IceCure Medical in a research report on Wednesday, November 27th.

IceCure Medical Company Profile

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.